Tower Research Capital LLC (Trc) Vir Biotechnology, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,637 shares of VIR stock, worth $20,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,637

Previous 8,005 54.57%

Holding current value

$20,476

Previous $40,000 50.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$4.28 - $5.93 $18,695 - $25,902	-4,368 Reduced 54.57%	3,637 $20,000
Q2 2025 Aug 14, 2025	BUY	$4.5 - $6.48 $23,539 - $33,896	5,231 Added 188.57%	8,005 $40,000
Q1 2025 May 15, 2025	SELL	$6.48 - $12.48 $379,838 - $731,540	-58,617 Reduced 95.48%	2,774 $17,000
Q4 2024 Feb 13, 2025	BUY	$6.74 - $10.17 $312,587 - $471,664	46,378 Added 308.92%	61,391 $450,000
Q3 2024 Nov 14, 2024	SELL	$7.26 - $10.7 $36,655 - $54,024	-5,049 Reduced 25.17%	15,013 $112,000

Q2 2024 Aug 13, 2024	BUY	$7.63 - $12.66 $145,588 - $241,565	19,081 Added 1945.06%	20,062 $178,000
Q1 2024 May 15, 2024	SELL	$8.6 - $11.9 $125,284 - $173,359	-14,568 Reduced 93.69%	981 $9,000
Q4 2023 Feb 13, 2024	BUY	$7.76 - $10.29 $87,517 - $116,050	11,278 Added 264.06%	15,549 $156,000
Q3 2023 Nov 14, 2023	SELL	$9.14 - $24.62 $13,737 - $37,003	-1,503 Reduced 26.03%	4,271 $40,000
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $48,093 - $56,572	2,073 Added 56.01%	5,774 $141,000
Q1 2023 May 09, 2023	SELL	$22.26 - $30.85 $64,375 - $89,218	-2,892 Reduced 43.86%	3,701 $86,000
Q4 2022 Feb 10, 2023	SELL	$19.96 - $28.22 $2,075 - $2,934	-104 Reduced 1.55%	6,593 $167,000
Q3 2022 Nov 10, 2022	SELL	$18.26 - $31.1 $364,743 - $621,222	-19,975 Reduced 74.89%	6,697 $129,000
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $172,635 - $241,581	9,048 Added 51.34%	26,672 $680,000
Q1 2022 May 12, 2022	BUY	$21.19 - $40.01 $37,357 - $70,537	1,763 Added 11.12%	17,624 $453,000
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $418,311 - $729,783	13,507 Added 573.79%	15,861 $664,000
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $67,391 - $105,316	-1,931 Reduced 45.06%	2,354 $103,000
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $75,407 - $99,246	1,946 Added 83.2%	4,285 $202,000
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $25,312 - $79,830	961 Added 69.74%	2,339 $120,000
Q4 2020 Feb 16, 2021	SELL	$25.51 - $43.38 $1.11 Million - $1.89 Million	-43,664 Reduced 96.94%	1,378 $37,000
Q3 2020 Nov 16, 2020	BUY	$28.28 - $53.6 $1.17 Million - $2.22 Million	41,351 Added 1120.32%	45,042 $1.55 Million
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $102,941 - $176,651	3,691 New	3,691 $151,000
Q1 2020 May 15, 2020	SELL	$12.04 - $60.2 $22,972 - $114,861	-1,908 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$11.83 - $15.85 $22,571 - $30,241	1,908 New	1,908 $24,000

Others Institutions Holding VIR

# of Institutions

243

Shares Held

105M

Call Options Held

246K

Put Options Held

126K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $747M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Vir Biotechnology, Inc. Transaction History